AGL 38.40 Decreased By ▼ -1.18 (-2.98%)
AIRLINK 128.43 Decreased By ▼ -2.79 (-2.13%)
BOP 7.05 Increased By ▲ 0.24 (3.52%)
CNERGY 4.52 Decreased By ▼ -0.19 (-4.03%)
DCL 8.19 Decreased By ▼ -0.25 (-2.96%)
DFML 38.75 Decreased By ▼ -2.72 (-6.56%)
DGKC 78.76 Decreased By ▼ -3.33 (-4.06%)
FCCL 31.57 Decreased By ▼ -1.53 (-4.62%)
FFBL 70.98 Decreased By ▼ -1.89 (-2.59%)
FFL 12.13 Decreased By ▼ -0.13 (-1.06%)
HUBC 107.50 Decreased By ▼ -3.24 (-2.93%)
HUMNL 13.76 Decreased By ▼ -0.75 (-5.17%)
KEL 4.89 Decreased By ▼ -0.30 (-5.78%)
KOSM 7.23 Decreased By ▼ -0.38 (-4.99%)
MLCF 37.50 Decreased By ▼ -1.40 (-3.6%)
NBP 68.08 Increased By ▲ 4.07 (6.36%)
OGDC 186.00 Decreased By ▼ -6.82 (-3.54%)
PAEL 24.70 Decreased By ▼ -0.98 (-3.82%)
PIBTL 7.25 Decreased By ▼ -0.09 (-1.23%)
PPL 147.00 Decreased By ▼ -7.07 (-4.59%)
PRL 24.70 Decreased By ▼ -1.13 (-4.37%)
PTC 16.90 Decreased By ▼ -0.91 (-5.11%)
SEARL 79.21 Decreased By ▼ -3.09 (-3.75%)
TELE 7.38 Decreased By ▼ -0.38 (-4.9%)
TOMCL 32.50 Decreased By ▼ -0.96 (-2.87%)
TPLP 8.15 Decreased By ▼ -0.34 (-4%)
TREET 16.60 Decreased By ▼ -0.02 (-0.12%)
TRG 56.20 Decreased By ▼ -1.20 (-2.09%)
UNITY 27.80 Increased By ▲ 0.29 (1.05%)
WTL 1.32 Decreased By ▼ -0.05 (-3.65%)
BR100 10,301 Decreased By -203.1 (-1.93%)
BR30 30,327 Decreased By -899 (-2.88%)
KSE100 96,629 Decreased By -1450.3 (-1.48%)
KSE30 30,080 Decreased By -479.2 (-1.57%)

Taiwan is ready to produce its own Tamiflu, the antiviral avian flu drug, and will not let patent talks with Swiss drug maker Roche AG stand in the way, officials said.
The island's National Health Research Institute showed media late on Friday a generic version of Tamiflu produced by its laboratories, which it said was 99 percent similar to Roche's drug.
"The congress and the government in Taiwan have already decided to produce Tamiflu, starting from right now .... once we obtain the material," Su Ih-jen, head of the clinical division at the health institute, told Reuters.
The Taiwan government was among the first in the world to seek permission from Roche to make Tamiflu, but it has yet to receive an authorisation. "We have tried our best to negotiate with Roche. It means we have shown our goodwill to Roche and we appreciate their patent. But to protect our people is the utmost important thing," said Su, a former chief of the Centre for Disease Control.

Copyright Reuters, 2005

Comments

Comments are closed.